Human Pharmacokinetic (pk) Characterization of the Novel Dual-Action Anti-Her3/Egfr Antibody Mehd7945a (mehd) in Patients with Refractory/Recurrent Epithelial TumorsManuel Hidalgo,Antonio Calles,Dejan Juric,Rodrigo Dienstmann,Desamparados Roda Perez,Wells A. Messersmith,George R. Blumenschein,Jose Baselga,Josep Tabernero,Andres Cervantes-Ruiperez,Antonio Jimeno,Denise Jin,Shuang Bai,Pavel Gurevich,Ihsan Nijem,Scott N. Holden,John D. Davis,Wendy Halpern,Andrea Pirzkall,Yan XinJOURNAL OF CLINICAL ONCOLOGY（2012）引用 24|浏览44暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
